Rankings
▼
Calendar
ENGN Q2 2022 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena
ENGN
enGene Holdings Inc.
$359M
Q2 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$4M
Net Income
-$5M
EPS (Diluted)
$-0.34
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$159,736
Free Cash Flow
-$159,736
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$131M
Total Liabilities
$4M
Stockholders' Equity
$127M
Cash & Equivalents
$909,562
← FY 2022
All Quarters
Q3 2022 →